Fort Washington Investment Advisors Inc Biomarin Pharmaceutical Inc Transaction History

Fort Washington Investment Advisors Inc

$16.2 Billion
Q4 2024

A detailed history of Fort Washington Investment Advisors Inc transactions in Biomarin Pharmaceutical Inc stock. As of the latest transaction made, Fort Washington Investment Advisors Inc holds 715,500 shares of BMRN stock, worth $50.6 Million. This represents 0.29% of its overall portfolio holdings.

Number of Shares

715,500

Previous 727,670 1.67%

Holding current value

$50.6 Million

Previous $51.1 Million 8.05%

% of portfolio

0.29%

Previous 0.32%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Jan 17, 2025	SELL	$61.93 - $70.49 $753,688 - $857,863	-12,170 Reduced 1.67%	715,500 $47 Million
Q3 2024 Oct 25, 2024	SELL	$69.02 - $93.84 $17.3 Million - $23.6 Million	-250,968 Reduced 25.64%	727,670 $51.1 Million
Q2 2024 Jul 30, 2024	SELL	$74.43 - $92.22 $14 Million - $17.4 Million	-188,617 Reduced 16.16%	978,638 $80.6 Million
Q1 2024 May 13, 2024	BUY	$83.81 - $99.0 $139,627 - $164,934	1,666 Added 0.14%	1,167,255 $102 Million
Q4 2023 Jan 17, 2024	SELL	$76.22 - $98.51 $10.9 Million - $14.1 Million	-142,656 Reduced 10.9%	1,165,589 $112 Million
Q3 2023 Nov 07, 2023	BUY	$85.07 - $94.48 $10.8 Million - $12 Million	126,680 Added 10.72%	1,308,245 $116 Million
Q2 2023 Jul 28, 2023	BUY	$86.68 - $100.3 $3.19 Million - $3.69 Million	36,754 Added 3.21%	1,181,565 $102 Million
Q1 2023 Apr 28, 2023	SELL	$87.74 - $117.27 $109,148 - $145,883	-1,244 Reduced 0.11%	1,144,811 $111 Million
Q4 2022 Jan 30, 2023	BUY	$80.93 - $108.63 $37,146 - $49,861	459 Added 0.04%	1,146,055 $119 Million
Q3 2022 Oct 26, 2022	SELL	$82.16 - $96.94 $7.43 Million - $8.77 Million	-90,463 Reduced 7.32%	1,145,596 $97.1 Million
Q2 2022 Aug 05, 2022	BUY	$71.48 - $86.85 $75,054 - $91,192	1,050 Added 0.09%	1,236,059 $102 Million
Q1 2022 May 03, 2022	BUY	$74.28 - $92.69 $6.79 Million - $8.47 Million	91,378 Added 7.99%	1,235,009 $95.2 Million
Q4 2021 Feb 07, 2022	BUY	$71.72 - $91.47 $39.6 Million - $50.5 Million	551,729 Added 93.21%	1,143,631 $101 Million
Q3 2021 Nov 09, 2021	BUY	$74.77 - $85.47 $44.3 Million - $50.6 Million	591,902 New	591,902 $45.7 Million
Q1 2019 May 10, 2019	SELL	$84.2 - $98.62 $386,478 - $452,665	-4,590 Closed	0 $0
Q2 2018 Jul 27, 2018	SELL	$76.01 - $99.03 $15,202 - $19,806	-200 Reduced 4.18%	4,590 $432,000
Q1 2018 May 02, 2018	SELL	$77.67 - $92.63 $93,204 - $111,156	-1,200 Reduced 20.03%	4,790 $388,000
Q4 2017 Feb 12, 2018	SELL	$80.76 - $95.13 $12,921 - $15,220	-160 Reduced 2.6%	5,990 $534,000
Q3 2017 Nov 13, 2017	SELL	$80.6 - $94.95 $128,959 - $151,920	-1,600 Reduced 20.65%	6,150 $572,000
Q2 2017 Aug 10, 2017	BUY	N/A	7,750	7,750 $704,000

Others Institutions Holding BMRN

# of Institutions

628

Shares Held

183M

Call Options Held

Put Options Held

1.67M

View Full List

About BIOMARIN PHARMACEUTICAL INC

Ticker BMRN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 185,824,000
Market Cap $13.1B
Description
BioMarin Pharmaceutical Inc. develops and commercializes therapies for people with serious and life-threatening rare diseases and medical conditions. Its commercial products include Vimizim, an enzyme replacement therapy for the treatment of mucopolysaccharidosis (MPS) IV type A, a lysosomal storage disorder; Naglazyme, a recombinant form of N-a...

More about BMRN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Fort Washington Investment Advisors Inc , based on Form 13F filings with the SEC.

News

Stay updated on Fort Washington Investment Advisors Inc with notifications on news.

Account

Fort Washington Investment Advisors Inc Biomarin Pharmaceutical Inc Transaction History